Cosmos Health (COSM) announces the first purchase order to market and distribute Virax Biolabs’ (VRAX) ViraxClear branded COVID-19 and Influenza A+B Antigen Combo Rapid Detection Kits. Pursuant to its previously signed distribution agreement dated September 2022, Cosmos Health will have exclusive distribution rights for Greece and Cyprus, with the opportunity to distribute the ViraxClear branded test kits across Europe on a non-exclusive basis.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on COSM:
- Virax Biolabs signs purchase order with Cosmos Health
- Cosmos Health announces appointment of Nikos Bardakis as COO
- Cosmos Health announces $3M stock buyback program
- Cosmos Health Renegotiates Better Terms for ZipDoctor; Tanks on Trading Pattern Review
- Cosmos Holdings extends and updates agreement to acquire ZipDoctor
